Abstract
Objective
To evaluate if pRCCs demonstrate intracellular lipid (i-lipid) at chemical-shift (CS) MRI, and assess T2W-MRI and pathologic characteristics.
Methodology
Sixty-two patients with a pRCC diagnosis underwent MRI over 11 years (IRB-approved). Two radiologists independently assessed for presence of i-lipid on CS-MRI and homogeneity on T2W-MRI. Inter-observer agreement was assessed via an intraclass correlation and results were compared using the Chi-square test. Discordant cases were reviewed to establish consensus. T2W SI-ratios (SI.tumor/SI.kidney) and CS-SI index were compared using independent t-tests and Spearman correlation. Two pathologists re-evaluated the histopathology.
Results
Nine of the 62 pRCCs (14.5 %) demonstrated i-lipid; agreement was moderate (ICC = 0.63). Pathology review depicted clear cells in four tumours and foamy histiocytes in five tumours.
25.8-35.4 % (ICC = 0.65) of tumours were homogeneous on T2W-MRI. No pRCC with i-lipid was considered homogeneous (p = 0.01-0.04). Overall, T2W SI-ratio and CS-SI index were 0.89 (±0.29) and -3.63 % (-7.27 to 11.42). pRCC with i-lipid had significantly higher T2W SI-ratio (p = 0.003). There was a correlation between the CS-SI index and T2W SI-ratio, (r = 0.44, p < 0.001).
Conclusions
Intracellular lipid is uncommonly detected in pRCCs due to clear cell changes and foamy histiocytes. These tumours are associated with heterogeneously-increased SI in T2W-MRI.
Key Points
• A minority of pRCCs demonstrate intracellular lipid in CS-MRI.
• Quantitatively, intracellular lipid in pRCCs is minimal (<25 %).
• Intracellular lipid in pRCCs are from clear cell heterogeneity or foamy histiocytes.
• pRCCs with intracellular lipid are heterogeneously hyperintense at T2W-MRI.
• pRCCs that are homogeneously hypointense at T2W-MRI do not contain intracellular lipid.
Similar content being viewed by others
References
Pedrosa I, Sun MR, Spencer M et al (2008) MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. Radiographics 28:985–1003
Cornelis F, Tricaud E, Lasserre AS et al (2014) Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours. Eur Radiol 24:1068–1080
Beddy P, Genega EM, Ngo L et al (2014) Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma. Clin Genitourin Cancer 12:55–62
Outwater EK, Bhatia M, Siegelman ES, Burke MA, Mitchell DG (1997) Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images. Radiology 205:103–107
Hindman N, Ngo L, Genega EM et al (2012) Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology 265:468–477
Karlo CA, Donati OF, Burger IA et al (2013) MR imaging of renal cortical tumours: qualitative and quantitative chemical shift imaging parameters. Eur Radiol 23:1738–1744
Sasiwimonphan K, Takahashi N, Leibovich BC, Carter RE, Atwell TD, Kawashima A (2012) Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology 263:160–168
Chung MS, Choi HJ, Kim MH, Cho KS (2014) Comparison of t2-weighted MRI with and without fat suppression for differentiating renal angiomyolipomas without visible fat from other renal tumors. AJR Am J Roentgenol 202:765–771
Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H (2003) Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 170:2217–2220
Remzi M, Ozsoy M, Klingler HC et al (2006) Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol 176:896–899
Violette P, Abourbih S, Szymanski KM et al (2012) Solitary solid renal mass: can we predict malignancy? BJU Int 110:E548–552
Fujii Y, Komai Y, Saito K et al (2008) Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology 72:598–602
Kutikov A, Fossett LK, Ramchandani P et al (2006) Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology 68:737–740
Rosenkrantz AB, Hindman N, Fitzgerald EF, Niver BE, Melamed J, Babb JS (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol 195:W421–427
Schieda N, McInnes MD, Cao L (2014) Diagnostic accuracy of segmental enhancement inversion for diagnosis of renal oncocytoma at biphasic contrast enhanced CT: systematic review. Eur Radiol
Yang CW, Shen SH, Chang YH et al (2013) Are there useful CT features to differentiate renal cell carcinoma from lipid-poor renal angiomyolipoma? AJR Am J Roentgenol 201:1017–1028
Schieda N HT, El-Khodary M, McInnes MDF (2014 (In Press)) Non-contrast enhanced computed tomography (NECT) for the diagnosis of minimal fat renal angiomyolipoma (AML). American Journal of Roentgenology
Israel GM, Hindman N, Hecht E, Krinsky G (2005) The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas. AJR Am J Roentgenol 184:1868–1872
Vargas HA, Chaim J, Lefkowitz RA et al (2012) Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. Radiology 264:779–788
Kim JK, Kim SH, Jang YJ et al (2006) Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging. Radiology 239:174–180
Kim JY, Kim JK, Kim N, Cho KS (2008) CT histogram analysis: differentiation of angiomyolipoma without visible fat from renal cell carcinoma at CT imaging. Radiology 246:472–479
Jinzaki M, Tanimoto A, Narimatsu Y et al (1997) Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology 205:497–502
Choi HJ, Kim JK, Ahn H, Kim CS, Kim MH, Cho KS (2011) Value of T2-weighted MR imaging in differentiating low-fat renal angiomyolipomas from other renal tumors. Acta Radiol 52:349–353
Chaudhry HS, Davenport MS, Nieman CM, Ho LM, Neville AM (2012) Histogram analysis of small solid renal masses: differentiating minimal fat angiomyolipoma from renal cell carcinoma. AJR Am J Roentgenol 198:377–383
Catalano OA, Samir AE, Sahani DV, Hahn PF (2008) Pixel distribution analysis: can it be used to distinguish clear cell carcinomas from angiomyolipomas with minimal fat? Radiology 247:738–746
Schieda N, Avruch L, Flood TA (2014) Small (<1 cm) incidental echogenic renal cortical nodules: chemical shift MRI outperforms CT for confirmatory diagnosis of angiomyolipoma (AML). Insights Imaging
Tanaka H, Yoshida S, Fujii Y et al (2011) Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. Int J Urol 18:727–730
Lassel EA, Rao R, Schwenke C, Schoenberg SO, Michaely HJ (2014) Diffusion-weighted imaging of focal renal lesions: a meta-analysis. Eur Radiol 24:241–249
Reuter VE (2006) The pathology of renal epithelial neoplasms. Semin Oncol 33:534–543
30 Eble JN SG, Epstein JI, Sesterhenn IA (2004) World Health Organization classification of tumors: Pathology and genetics of tumors of the urinary system and male genital organs. Lyon, Fr. Available via http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb7/BB7.pdf2013
Delahunt B, Eble JN (1997) Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10:537–544
Lefevre M, Couturier J, Sibony M et al (2005) Adult papillary renal tumor with oncocytic cells: clinicopathologic, immunohistochemical, and cytogenetic features of 10 cases. Am J Surg Pathol 29:1576–1581
Renshaw AA, Corless CL (1995) Papillary renal cell carcinoma. Histology and immunohistochemistry. Am J Surg Pathol 19:842–849
Thoenes W, Storkel S, Rumpelt HJ, Moll R, Baum HP, Werner S (1988) Chromophobe cell renal carcinoma and its variants–a report on 32 cases. J Pathol 155:277–287
Garin JM, Marco I, Salva A, Serrano F, Bondia JM, Pacheco M (2007) CT and MRI in fat-containing papillary renal cell carcinoma. Br J Radiol 80:e193–195
Schuster TG, Ferguson MR, Baker DE, Schaldenbrand JD, Solomon MH (2004) Papillary renal cell carcinoma containing fat without calcification mimicking angiomyolipoma on CT. AJR Am J Roentgenol 183:1402–1404
Mai KT, Faraji H, Desantis D, Robertson SJ, Belanger EC, Levac J (2010) Renal cell carcinoma with mixed features of papillary and clear cell cytomorphology: a fluorescent in situ hybridization study. Virchows Arch 456:77–84
Mai KT, Kohler DM, Roustan Delatour NL, Veinot JP (2006) Cytohistopathologic hybrid renal cell carcinoma with papillary and clear cell features. Pathol Res Pract 202:863–868
Aydin H, Chen L, Cheng L et al (2010) Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol 34:1608–1621
Campbell N, Rosenkrantz AB, Pedrosa I (2014) MRI phenotype in renal cancer: is it clinically relevant? Top Magn Reson Imaging 23:95–115
Ramamurthy NK MB, McInnes MDF, Flood TA, Schieda N (2014) Multi-parametric (MP) MRI of solid renal masses: Pearls and Pifalls. Clinical Radiology
Acknowledgements
The scientific guarantor of this publication is Nicola Schieda, MD. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. Nicola Schieda MD, has significant statistical expertise. Institutional Review Board approval was obtained. Written informed consent was waived by the Institutional Review Board. Methodology: retrospective, cross sectional study, performed at one institution.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schieda, N., van der Pol, C.B., Moosavi, B. et al. Intracellular lipid in papillary renal cell carcinoma (pRCC): T2 weighted (T2W) MRI and pathologic correlation. Eur Radiol 25, 2134–2142 (2015). https://doi.org/10.1007/s00330-015-3610-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-015-3610-x